Related Experiment Video
Updated: Jun 11, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
ISCOMATRIX() vaccines: Safety in human clinical studies
Andrew McKenzie1, Marli Watt, Charmaine Gittleson
1CSL Limited, Parkville, VIC, Australia.
Human Vaccines
|July 3, 2010
Summary
ISCOMATRIX() adjuvant is safe in developmental vaccines. While some participants experienced mild, temporary side effects, no serious adverse events or deaths were linked to the adjuvant.
Area of Science:
- Immunology
- Vaccinology
Background:
- ISCOMATRIX() adjuvant is utilized in various developmental vaccines.
- Assessing vaccine adjuvant safety is crucial for public health.
Purpose of the Study:
- To evaluate the safety and tolerability of ISCOMATRIX() adjuvant.
- To analyze pooled safety data from multiple vaccine development programs.
Main Methods:
- Pooled analysis of safety data from ISCOMATRIX() adjuvant vaccine trials.
- Comparison of reactogenicity and adverse events between ISCOMATRIX() vaccines, placebo, and active comparators.
- Review of laboratory safety parameters and specific event databases (autoimmune, allergic).
Main Results:
- ISCOMATRIX() vaccines were safe and well-tolerated, with no vaccine-related deaths or Serious Adverse Events (SAEs).
- Increased local and systemic reactogenicity was observed with ISCOMATRIX() vaccines, but it was generally mild and self-limiting.
- No evidence suggested ISCOMATRIX() adjuvant was associated with autoimmune or allergic disorders, including anaphylaxis.
Conclusions:
- ISCOMATRIX() adjuvant demonstrates a favorable safety profile in developmental vaccines.
- The adjuvant is well-tolerated, with manageable reactogenicity and no links to serious immune-related events.
- Ongoing studies continue to monitor the long-term safety of ISCOMATRIX() adjuvant.
Related Concept Videos
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...